<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37089085</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>20</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1747-4949</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>International journal of stroke : official journal of the International Stroke Society</Title><ISOAbbreviation>Int J Stroke</ISOAbbreviation></Journal><ArticleTitle>Severe lupus flare is associated with a much higher risk of stroke among patients with SLE.</ArticleTitle><Pagination><StartPage>957</StartPage><EndPage>964</EndPage><MedlinePgn>957-964</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/17474930231174227</ELocationID><Abstract><AbstractText Label="BACKGROUND AND AIM">There are few data on the influence of lupus flare on stroke risk in systemic lupus erythematosus (SLE). In this study, we examined whether a severe lupus flare further increases the risk of stroke among SLE patients.</AbstractText><AbstractText Label="METHODS">Using the Taiwan's National Health Insurance Research Database, we conducted a retrospective population-based cohort study from 2000 to 2016. Each patient with SLE was matched to a non-SLE subject in age, sex, and index date. A severe flare of lupus was identified when an SLE patient was admitted for pulse therapy with intravenous methylprednisolone greater than 250&#x2009;mg in a single hospitalization. SLE patients were divided into severe flare and non-severe flare groups.</AbstractText><AbstractText Label="RESULTS">In total, 334 of 10,006 patients with SLE had a severe lupus flare, and the remaining 9672 patients were assigned to the non-severe flare group. Ischemic stroke occurred in 29 (8.7%), 485 (5%), and 384 (3.8%) of the patients in the severe flare, non-severe flare, and control groups, respectively. Hemorrhagic stroke occurred in 9 (2.7%), 123 (1.3%), and 37 (0.4%) of patients in the severe flare, non-severe flare, and control groups, respectively. Compared with patients in the non-severe flare group, patients with severe flare had a significantly higher risk of ischemic stroke (adjusted hazard ratio (aHR)&#x2009;=&#x2009;7.44, 95% confidence interval (CI): 4.93-11.25 vs aHR&#x2009;=&#x2009;1.52, 95% CI: 1.26-1.83) and hemorrhagic stroke (aHR&#x2009;=&#x2009;22.49, 95% CI: 10.09-50.12 vs aHR&#x2009;=&#x2009;4.47, 95% CI: 2.90-6.90).</AbstractText><AbstractText Label="CONCLUSION">Severe lupus flare is associated with a much higher risk of ischemic and hemorrhagic strokes among SLE patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Kuo-Cheng</ForeName><Initials>KC</Initials><AffiliationInfo><Affiliation>Division of Neurology, Neurological Institute, Taichung Veterans General Hospital, Taichung.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Ching-Heng</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Department of Medical Research, Taichung Veterans General Hospital, Taichung.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Po-Lin</ForeName><Initials>PL</Initials><Identifier Source="ORCID">0000-0002-7254-0108</Identifier><AffiliationInfo><Affiliation>Division of Neurology, Neurological Institute, Taichung Veterans General Hospital, Taichung.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Brain Science, School of Medicine, National Yang Ming Chiao Tung University, Taipei.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Yu-Hsuan</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Division of Neurology, Neurological Institute, Taichung Veterans General Hospital, Taichung.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Chung-Wei</ForeName><Initials>CW</Initials><AffiliationInfo><Affiliation>Division of Neurology, Neurological Institute, Taichung Veterans General Hospital, Taichung.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Jin-An</ForeName><Initials>JA</Initials><Identifier Source="ORCID">0000-0003-1275-059X</Identifier><AffiliationInfo><Affiliation>Division of Neurology, Neurological Institute, Taichung Veterans General Hospital, Taichung.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Business Administration, Hungkuang University, Taichung.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Stroke</MedlineTA><NlmUniqueID>101274068</NlmUniqueID><ISSNLinking>1747-4930</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000083302" MajorTopicYN="Y">Hemorrhagic Stroke</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000067251" MajorTopicYN="N">Symptom Flare Up</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000083242" MajorTopicYN="Y">Ischemic Stroke</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Stroke</Keyword><Keyword MajorTopicYN="N">lupus flare</Keyword><Keyword MajorTopicYN="N">systemic lupus erythematosus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>20</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>24</Day><Hour>3</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37089085</ArticleId><ArticleId IdType="doi">10.1177/17474930231174227</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>